Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF.

Eur Respir J

Dept of Internal Medicine V, University of Munich, Comprehensive Pneumology Center, member of the German Center for Lung Research (DZL), Munich, Germany Dept of Respiratory Medicine, Asklepios Clinic Gauting, Comprehensive Pneumology Center, member of the German Center for Lung Research (DZL), Munich, Germany.

Published: October 2015

Download full-text PDF	Source
http://dx.doi.org/10.1183/13993003.00584-2015	DOI Listing

Publication Analysis

switching nintedanib

nintedanib discontinuation

discontinuation pirfenidone

pirfenidone adverse

adverse events

events ipf

switching

discontinuation

pirfenidone

adverse

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!